Equity Research, Broker Reports, and media content on BAVARIAN NORDIC A S

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about BAVARIAN NORDIC A S
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on BAVARIAN NORDIC A S. We currently have 5 research reports from 1 professional analysts.

Open
277
Volume
0.1m
Range
276/280
Market Cap
8,779,076,320m
52 Week
197/306
Date Source Announcement
23Feb17 15:21 GNW Updated Phase 1 Data Show Bavarian Nordic's Vaccine Candidate Induces a Broad and Durable Immune Response against RSV
17Jan17 07:00 GNW Henrik Birk Appointed Chief Operating Officer of Bavarian Nordic
04Jan17 13:26 GNW Bavarian Nordic Provides Update on Anticipated Timing of PROSPECT Study
03Jan17 10:24 GNW Bavarian Nordic Upgrades its Expectations for 2016 Year-end Cash Preparedness
29Dec16 12:00 GNW Bavarian Nordic Initiates Trial of CV301 in Combination with Nivolumab in Patients with Lung Cancer
23Nov16 14:23 GNW Bavarian Nordic Completes Enrollment of Phase 3 Non-inferiority Study of IMVAMUNE® Smallpox Vaccine
23Nov16 09:06 GNW Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
  • Frequency of research reports

     

  • Research reports on

    BAVARIAN NORDIC A S

  • Providers covering

    BAVARIAN NORDIC A S

Latest Content

View the latest research, videos, and podcasts for this company.